Study sites in the Mekong region where <i>S.</i> Typhi has been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see Table S1).

<p>Study sites in the Mekong region where <i>S.</i> Typhi has been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044269#pone.0044269.s001" target="_blank">Table S1</a>).</p

Pop-up window of map showing study sites in the Mekong region where major aetiologies of febrile illnesses have been reported.

<p>Pop-up window of map showing study sites in the Mekong region where major aetiologies of febrile illnesses have been reported.</p

Criteria used for selection of papers for the mapping of aetiology of non-malaria febrile illness in Southeast Asia.

<p>Criteria used for selection of papers for the mapping of aetiology of non-malaria febrile illness in Southeast Asia.</p

Study sites in the Mekong region where <i>Leptospira</i> spp. have been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see Table S1).

<p>Study sites in the Mekong region where <i>Leptospira</i> spp. have been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044269#pone.0044269.s001" target="_blank">Table S1</a>).</p

Study sites in the Mekong region where other viral infections (e.g. hepatitis viruses, herpes simplex viruses, and enterovirus) have been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see Table S1).

<p>Study sites in the Mekong region where other viral infections (e.g. hepatitis viruses, herpes simplex viruses, and enterovirus) have been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044269#pone.0044269.s001" target="_blank">Table S1</a>).</p

Study sites in the Mekong region where Dengue virus has been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see Table S1).

<p>Study sites in the Mekong region where Dengue virus has been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044269#pone.0044269.s001" target="_blank">Table S1</a>).</p

Parasites curves following CQ-treatment according <i>Pfmdr-1</i> alleles.

<p>Asexual parasites curves following CQ-treatment according <i>Pfmdr-1</i> mutation at position 86 in isolates from patients included in the analysis, Madagascar in 2006–2007.</p

Study sites in the Mekong region where major aetiologies of infectious febrile illnesses have been reported.

<p>Study sites in the Mekong region where major aetiologies of infectious febrile illnesses have been reported.</p

Study sites in the Mekong region where Rickettsioses have been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see Table S1).

<p>Study sites in the Mekong region where Rickettsioses have been reported, illustrating frequency of identification (case) based on assays and sample population used in the study (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044269#pone.0044269.s001" target="_blank">Table S1</a>).</p

Curves of cumulative incidence of recurrence of patients over the 28-day follow-up period.

<p>Kaplan-Meier curves of cumulative incidence of recurrence of patients over the 28-day follow-up period according <i>Pfmdr-1</i> mutation at position 86 in isolates of day of recurrence from patients included in the analysis, Madagascar in 2006–2007.</p